CellAegis Devices, a medical device company that treats cardiovascular and cerebrovascular diseases, received an investment of 60 million yuan
Recently, CellAegis Devices, a medical device company from Toronto, announced the completion of a $9.5 million (more than 60 million yuan) Series C financing. This round of financing was led by Canada's leading venture capital firm CTI Life Sciences Fund. Other investors include MaRS Catalyst Fund, Broadview Ventures and a number of investors from the United States. In addition, Dr. Shermaine Tilley, managing partner of CTI Life Sciences Fund, and Christopher Colecchi, managing partner of Broadview Ventures, will join the board of directors of CellAegis Devices. It is reported that the company will use this round of funds to promote the autoRIC equipment of its products for clinical trials in the United States. AutoRIC is a portable automated Remote Ischemic Conditioning (RIC) processing device. The concept of ischemic preconditioning was proposed by Dr. CE Murry in the United States in 1986 to stimulate the body's immune system to produce and release endogenous protective substances such as adenosine and bradykinin by performing short-term, non-hazardous ischemic training on the human body. Nitric oxide, etc. (these substances participate in human energy metabolism and myocardial protection) to alleviate the serious damage caused by ischemia and hypoxia in the future. Distal ischemic adaptation (RIC) is to induce the body to produce tolerance to ischemia and hypoxia through blood flow blockage and reflow stimulation of non-essential organs (such as limbs), so that distant vital organs (heart, brain) , liver, kidney, etc.) to provide a protective mechanism for severely lethal ischemia and hypoxia. Remote ischemic adaptation is an innovative means to prevent and treat ischemic heart and cerebrovascular diseases. It can be used for myocardial infarction, heart surgery, stroke, trauma and organ transplantation, etc., and it can effectively avoid cerebral infarction. Sudden occurrence of cardiovascular and cerebrovascular diseases such as sudden cardiac death. â–²This autoRIC device schematic (Source: CellAegis official website) In general, inflating a standard blood pressure cuff can trigger limb ischemia, and CellAegis' autoRIC device enables automated non-invasive remote ischemic training, which can complete 4 cycles of training in 40 minutes. At the same time, the device is easy to carry and can be used in hospitals, ambulances and homes. Orange Diamond Nitrile Blend Gloves
Diamond Orange Advance Powder-Free Disposable Nitrile Gloves 6 Mil Heavy Duty Orange Diamond Nitrile Blend Gloves,Diamond Eco Nitrile Gloves,Diamond Nitrile Exam Gloves,Microflex Diamond Grip Nitrile Gloves Jiangsu Asbao Medical Technology Co., Ltd. , https://www.iigloves.com
Orange Industrial Gloves Black Xl Einweghandschuhe 9mil Heavy Duty Brand Diamond Texture Nitrile Gloves for mechanic work
